REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,587,286 | +497.5% | 1,321,795 | +325.7% | 1.22% | +585.4% |
| Q3 2022 | $6,123,000 | -31.0% | 310,500 | +38.5% | 0.18% | +87.4% |
| Q4 2020 | $8,877,000 | +13.8% | 224,224 | 0.0% | 0.10% | -16.7% |
| Q3 2020 | $7,803,000 | -29.4% | 224,224 | -35.9% | 0.11% | -36.3% |
| Q2 2020 | $11,050,000 | +41.4% | 350,000 | 0.0% | 0.18% | -12.3% |
| Q1 2020 | $7,816,000 | – | 350,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $139,040,000 | 34.79% |
| Ponoi II Management, LLC | 685,011 | $17,242,000 | 31.32% |
| Nextech Invest Ltd. | 2,968,214 | $74,710,000 | 19.68% |
| Ponoi Management, LLC | 685,011 | $17,242,000 | 15.90% |
| Column Group LLC | 3,347,245 | $84,250,000 | 11.46% |
| TRV GP IV, LLC | 1,419,900 | $35,739,000 | 10.28% |
| Cormorant Asset Management, LP | 2,431,852 | $61,210,000 | 3.64% |
| Boxer Capital, LLC | 3,484,264 | $87,699,000 | 3.41% |
| Casdin Capital, LLC | 2,370,000 | $59,653,000 | 1.68% |
| BVF INC/IL | 1,810,549 | $45,572,000 | 1.65% |